Colorectal cancer is the third most common cancer worldwide, resulting in 50,000 deaths annually in the U.S. alone.

The University of Washington is offering new hope for people who have suffered a stroke by implanting a device directly in ...

Precision medicine revolutionizes cancer care, empowering patients with personalized insights and targeted therapies while ...

Machine learning holds promise for optimizing treatment strategies and potentially improving outcomes in respiratory failure ...

Q1 2026 Earnings Call Transcript August 7, 2025 Doximity, Inc. beats earnings expectations. Reported EPS is $0.36, ...

August 7, 2025Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.46 EPS, expectations were $-0.44. Operator: Good morning. My name is John, and I'll be your conference ...

Dynavax Technologies Corporation (NASDAQ: DVAX) Q2 2025 Earnings Call Transcript August 7, 2025 Dynavax Technologies ...

There are mad inventions, such as weight-loss drugs or the contraceptive Pill, that come out of the blue and change the world ...

Results from the Phase III EPCORE FL-1 trial (NCT05409066) showed that patients treated with Epkinly (epcoritamab) in combination with Rituxan (rituximab) and Revlimid (lenalidomide) for relapsed or ...

While DCTs failed to transform clinical research, artificial intelligence (AI)-powered study approaches are now fulfilling their promise within the non-interventional research space. Unified, digital ...

This program has transformed not only my attitudes and behaviors towards brain health, but also those of my daughter,” and in ...

ProteinQure gets US FDA and Health Canada regulatory clearances to begin phase I trial of PQ203 in US and Canada: Toronto Saturday, August 9, 2025, 16:00 Hrs [IST] ProteinQure, a ...